Both in Pharmaceuticals
Innoviva vs Phibro Animal Health
Over the past year INVA returned +17.2% and PAHC returned −10.4%; their daily moves had a correlation of 0.21.
INVA +17.2% PAHC −10.4%Growth of $1, one year, split-adjusted
| Metric | INVA | PAHC |
|---|---|---|
| Price | $21.22 | $38.88 |
| Market cap | $1.53B | $1.58B |
| Today | −0.42% | +0.05% |
| 1 month | +3.3% | +8.4% |
| 6 months | −8.2% | −29.2% |
| Year to date | +6.2% | +4.1% |
| 1 year | +20.8% | −5.6% |
| Revenue growth (YoY) | +19.3% | +4.8% |
| Gross margin | 81.3% | 33.9% |
| Net margin | −69.8% | 5.5% |
| P/E (TTM) | 4.3× | 15.8× |
| Price / sales | 3.5× | 1.0× |
| Net cash | $319.0M | -$650.8M |
| Dividend yield | — | 1.23% |
| Volatility (60d) | 21.7% | 30.4% |
| Short % of float | 10.5% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).